Genomictree's IPO

Genomictree raised a round of funding on July 19, 2016. Investors include Public.

Genomictree (지노믹트리) (KONEX: 228760), founded in 2000, is a global molecular diagnostic corporation that has developed and commercialized DNA methylation biomarker-based non-invasive cancer m…

Articles about Genomictree's IPO: